In a report released today, Joshua Spector from UBS maintained a Buy rating on Linde (LIN – Research Report), with a price target of $482.00. The company’s shares closed yesterday at $463.61.
Spector covers the Basic Materials sector, focusing on stocks such as Albemarle, Cabot, and Eastman Chemical. According to TipRanks, Spector has an average return of 5.0% and a 56.02% success rate on recommended stocks.
Linde has an analyst consensus of Moderate Buy, with a price target consensus of $457.00.
See Insiders’ Hot Stocks on TipRanks >>
Based on Linde’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $8.3 billion and a net profit of $1.54 billion. In comparison, last year the company earned a revenue of $7.9 billion and had a net profit of $1.33 billion
Based on the recent corporate insider activity of 32 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LIN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Linde (LIN) Company Description:
Founded in 2017, UK-based Linde Plc is a leading global industrial gases and engineering company. The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals. Linde generates revenues through the following segments: Americas, EMEA (Europe, Middle East & Africa), APAC (Asia Pacific), Engineering and Others.
Read More on LIN:
